Seroprevalence of Helicobacter pylori infection in cystic fibrosis and its cross-reactivity with anti-pseudomonas antibodies.

BACKGROUND The prevalence of Helicobacter pylori infection and its role in gastroduodenal disease in cystic fibrosis (CF) are controversial. Additionally, serologic determination of infection in this population may be inaccurate because of cross-reactivity with other bacterial species. The seroprevalence of H. pylori in a cohort of patients with CF and its cross-reactivity with Pseudomonas antibodies were investigated. METHODS A research enzyme-linked immunosorbent assay (ELISA), and three commercial serologic assays (PyloriStat; BioWhittaker, Walkersville, MD, U.S.A.; Flexsure; SmithKline Diagnostics, Inc., San Jose, CA, U.S.A.; and HM-CAP; EPI, Stony Brook, NY, U.S.A.) at three independent laboratories determined the seroprevalence of anti-H. pylori IgG antibodies in 70 patients with CF. Cross-reactivity between solid-phase H. pylori antigens and Pseudomonas antibodies was ascertained by a competitive inhibition assay, preadsorbing sera of patients with CF with whole cell proteins from different Pseudomonas species, and serum reanalysis by each assay. Western blot analysis before and after adsorption was performed to identify potential cross-reactive antigens. RESULTS The research ELISA, Flexsure, Pyloristat, and HM-CAP initially showed H. pylori seropositivity of 47%, 28%, 24%, and 37%, respectively. Postadsorption seropositivity declined to 8%, 0%, 0%, and 15%, respectively. All patients with research ELISA true-positive results were confirmed endoscopically to have H. pylori infection. Western blot analysis showed a 31-kDa H. pylori protein with antigenic epitopes common to both bacterial species. CONCLUSIONS Cross-reactivity between solid-phase H. pylori antigens and anti-Pseudomonas antibodies occurs in patients with CF. A high index of suspicion should be assumed in evaluating results of serologic H. pylori tests in this population. Preadsorption of CF sera with Pseudomonas proteins should be used in serologic testing.

[1]  B. Marshall,et al.  Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection , 1999, American Journal of Gastroenterology.

[2]  W. Chey,et al.  A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial , 1999, American Journal of Gastroenterology.

[3]  J. Thomas,et al.  Seroepidemiology of Helicobacter pylori infection in an urban, upper class population in Chennai. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[4]  S. Czinn.  Serodiagnosis of Helicobacter pylori in pediatric patients. , 1999, Journal of pediatric gastroenterology and nutrition.

[5]  Benjamin L. King,et al.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori , 1999, Nature.

[6]  P. Fields,et al.  Use caution with serologic testing for Helicobacter pylori infection in children. , 1998, The Journal of infectious diseases.

[7]  Woo-Kon Lee,et al.  Comparison of Helicobacter pylori Infection between Fukuoka, Japan and Chinju, Korea , 1998, Helicobacter.

[8]  E. Gouws,et al.  Seroepidemiological study of Helicobacter pylori infection in South African children. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  N. Banatvala,et al.  Helicobacter pylori Acquisition in Infancy after Decline of Maternal Passive Immunity1 , 1997, Pediatric Research.

[10]  A. Cutler.  Testing for Helicobacter pylori in clinical practice. , 1996, The American journal of medicine.

[11]  N. Banatvala,et al.  HELICOBACTER PYLORI ACQUISITION IN INFANCY FOLLOWING DECLINE OF MATERNAL PASSIVE IMMUNITY , 1995, Journal of Pediatric Gastroenterology and Nutrition.

[12]  N. Høiby,et al.  Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori , 1995, Clinical and diagnostic laboratory immunology.

[13]  M. Blaser,et al.  Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. , 1994, Clinical and diagnostic laboratory immunology.

[14]  B. Drumm,et al.  Helicobacter pylori in the pediatric patient. , 1993, Gastroenterology clinics of North America.

[15]  L. Andersen,et al.  Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique , 1992, Journal of clinical microbiology.

[16]  Matthew P. Anderson,et al.  Cystic fibrosis transmembrane conductance regulator: A chloride channel with novel regulation , 1992, Neuron.

[17]  M. Faulde,et al.  Evaluation of an immunofluorescence assay for specific detection of immunoglobulin G antibodies directed against Helicobacter pylori, and antigenic cross-reactivity between H. pylori and Campylobacter jejuni , 1991, Journal of clinical microbiology.

[18]  M. Blaser.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. , 1990, The Journal of infectious diseases.

[19]  A. Bauernfeind,et al.  Seroimmunological monitoring of Campylobacter pylori in patients with cystic fibrosis , 1989 .

[20]  F. Mégraud,et al.  Seroepidemiology of Campylobacter pylori infection in various populations , 1989, Journal of clinical microbiology.

[21]  M. Blaser,et al.  Campylobacter pylori antibodies in humans. , 1988, Annals of internal medicine.

[22]  M. Blaser,et al.  Conservation and diversity of Campylobacter pyloridis major antigens , 1987, Infection and immunity.

[23]  M. Blaser,et al.  Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa, and Vibrio cholerae are immunologically related to Campylobacter spp , 1986, Infection and immunity.

[24]  V. Hubbard.  Gastrointestinal Complications in Cystic Fibrosis , 1985 .

[25]  K. Gaskin,et al.  Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. , 1985, The New England journal of medicine.

[26]  N. Høiby,et al.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis , 1983, Infection and Immunity.

[27]  P. B. Fernandes,et al.  Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients , 1981, Infection and immunity.

[28]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[29]  L. Zöller,et al.  Humoral immune response against Helicobacter pylori as determined by immunoblot , 1993, Electrophoresis.

[30]  J. Littlewood.  Cystic fibrosis: gastrointestinal complications. , 1992, British medical bulletin.

[31]  D. Newell.  Identification of the outer membrane proteins of Campylobacter pyloridis and antigenic cross-reactivity between C. pyloridis and C. jejuni. , 1987, Journal of general microbiology.